Dihydromyricetin: an Emerging Compound with Comprehensive Effects on Multiple Systems

Overview

Journal Front Pharmacol

Date 2025 Jan 20

PMID 39830336

Authors

Chengyi He

Yunfei Chen

Jiao Xie

Miao Luo

David Fisher

Nguyen Thi Thu Hien

Erkin Musabaev

Yiping Dang

Lei Zhao

Yin Xia

Affiliations

Soon will be listed here.

Abstract

Dihydromyricetin (DHM or DMY) is a flavonoid derived from natural sources with a range of confirmed biological benefits. It exhibits anti-inflammatory, antioxidant, anti-tumor, and anti-viral activities. DHM is recognized for its high biosafety, making it a promising subject for further research. This article offers a comprehensive overview of DHM's pharmacological properties, mechanisms, and recent research developments in the cardiovascular, urinary, digestive, nervous, and respiratory systems. The review summarizes DHM's biological effects and associated signaling pathways, providing novel insights for its clinical application.

References

Wang S, Zhang J, Deng X, Zhao Y, Xu K . Advances in characterization of SIRT3 deacetylation targets in mitochondrial function. Biochimie. 2020; 179:1-13. DOI: 10.1016/j.biochi.2020.08.021. View

Li X, Pang C, Peng Z, Zhuang Z, Lu Y, Li W . Dihydromyricetin confers cerebroprotection against subarachnoid hemorrhage via the Nrf2-dependent Prx2 signaling cascade. Phytomedicine. 2023; 119:154997. DOI: 10.1016/j.phymed.2023.154997. View

Silva J, Shao A, Shen Y, Davies D, Olsen R, Holschneider D . Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety. Front Pharmacol. 2020; 11:1008. PMC: 7364153. DOI: 10.3389/fphar.2020.01008. View

Xiong X, Xia M, Niu A, Zhang Y, Yin T, Huang Q . Dihydromyricetin contributes to weight loss via pro-browning mediated by mitochondrial fission in white adipose. Eur J Pharmacol. 2022; 935:175345. DOI: 10.1016/j.ejphar.2022.175345. View

Liu D, Mao Y, Ding L, Zeng X . Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability. Trends Food Sci Technol. 2020; 91:586-597. PMC: 7127391. DOI: 10.1016/j.tifs.2019.07.038. View

Wang J, Jiao P, Zhou Y, Liu Q . Protective Effect of Dihydromyricetin Against Lipopolysaccharide-Induced Acute Kidney Injury in a Rat Model. Med Sci Monit. 2016; 22:454-9. PMC: 4754091. DOI: 10.12659/msm.897076. View

Gong H, Xu H, Li M, Zhang D . Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease. Eur J Pharmacol. 2022; 935:175325. DOI: 10.1016/j.ejphar.2022.175325. View

Silva J, Yu X, Moradian R, Folk C, Spatz M, Kim P . Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism. Alcohol Clin Exp Res. 2020; 44(5):1046-1060. PMC: 7211127. DOI: 10.1111/acer.14326. View

Leng Q, Zhou J, Li C, Xu Y, Liu L, Zhu Y . Dihydromyricetin ameliorates diet-induced obesity and promotes browning of white adipose tissue by upregulating IRF4/PGC-1α. Nutr Metab (Lond). 2022; 19(1):38. PMC: 9188085. DOI: 10.1186/s12986-022-00672-6. View

10.

Wu J, Xiao Z, Li H, Zhu N, Gu J, Wang W . Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer. Cancers (Basel). 2022; 14(14). PMC: 9317349. DOI: 10.3390/cancers14143487. View

11.

Ni T, Lin N, Lu W, Sun Z, Lin H, Chi J . Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy. Cardiovasc Drugs Ther. 2020; 34(3):291-301. DOI: 10.1007/s10557-020-06968-0. View

12.

Pineton de Chambrun G, Blanc P, Peyrin-Biroulet L . Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2016; 10(8):915-27. DOI: 10.1586/17474124.2016.1174064. View

13.

Deng L, Xia T, Cheng W, Yang M, Zhu W, Chen X . Injectable redox albumin-based hydrogel with in-situ loaded dihydromyricetin. Colloids Surf B Biointerfaces. 2022; 220:112871. DOI: 10.1016/j.colsurfb.2022.112871. View

14.

Lan H, Wang H, Chen C, Hu W, Ai C, Chen L . Flavonoids and gastrointestinal health: single molecule for multiple roles. Crit Rev Food Sci Nutr. 2023; 64(30):10987-11005. DOI: 10.1080/10408398.2023.2230501. View

15.

Xiang D, Wang C, Wang W, Shi C, Xiong W, Wang M . Gastrointestinal stability of dihydromyricetin, myricetin, and myricitrin: an in vitro investigation. Int J Food Sci Nutr. 2017; 68(6):704-711. DOI: 10.1080/09637486.2016.1276518. View

16.

Yang D, Yang Z, Chen L, Kuang D, Zou Y, Li J . Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice. J Cell Mol Med. 2020; 24(10):5911-5925. PMC: 7214150. DOI: 10.1111/jcmm.15278. View

17.

Matouk A, Awad E, El-Tahawy N, El-Sheikh A, Anter A . Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity. Pharmaceuticals (Basel). 2023; 16(4). PMC: 10145727. DOI: 10.3390/ph16040481. View

18.

Ding Y, Gong W, Zhang S, Shen J, Liu X, Wang Y . Protective role of sirtuin3 against oxidative stress and NLRP3 inflammasome in cholesterol accumulation and foam cell formation of macrophages with ox-LDL-stimulation. Biochem Pharmacol. 2021; 192:114665. DOI: 10.1016/j.bcp.2021.114665. View

19.

Xie J, Zhang T, Li P, Wang D, Liu T, Xu S . Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis. Drug Des Devel Ther. 2022; 16:3071-3085. PMC: 9477154. DOI: 10.2147/DDDT.S378786. View

20.

Wei Y, Hu Y, Qi K, Li Y, Chen J, Wang R . Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway. Behav Brain Res. 2022; 423:113775. DOI: 10.1016/j.bbr.2022.113775. View